Why the study?
Do antithrombotic and thrombolytic therapies reduce mortality in patients with suspected acute myocardial infarction?
Do antithrombotic and thrombolytic therapies reduce mortality in patients with suspected acute myocardial infarction?
Wider and earlier utilization of aspirin and thrombolytic therapies in acute myocardial infarction is essential to reduce premature mortality.
No takes yet. Share an insight, caveat, or question.
May support expanded early antithrombotic use in AMI; leaves open precise benefits amid modern reperfusion.
Charles H. Hennekens (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: